rxstat › Classes › Antiinflammatory Agents

Antiinflammatory Agents: shortage status in Canada

4 of the 8 antiinflammatory agents rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.

Bromfenac (Prolensa) Partial shortage 1 of 2 reported products affected · est. return Mar 26, 2027 Diclofenac (Voltaren) Partial shortage 5 of 34 reported products affected · est. return Sep 18, 2026 Difluprednate (Durezol) Partial shortage 1 of 1 reported products affected Ketorolac Tromethamine (Toradol) Partial shortage 3 of 12 reported products affected · est. return Nov 6, 2026 Nepafenac (Nevanac) Shortage anticipated 0 of 2 reported products affected Dexamethasone (Maxidex) No current shortage Fluorometholone (Flarex) Discontinued 0 of 1 reported products affected Prednisolone (Pred Mild) No current shortage

Guides: what to do when your medication is in shortage · how to read these statuses

Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.